Barclays PLC Portfolio Holdings

Barclays PLC

  • $377 Billion
  • Q3 2024

Barclays PLC has filed its 13F form on November 19, 2024 for Q3 2024 where it was disclosed a total value porftolio of $377 Billion distributed in 9207 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Apple Inc. with a value of $13.4B, Microsoft Corp with a value of $13.2B, Nvidia Corp with a value of $11.9B, Amazon Com Inc with a value of $6.33B, and Alphabet Inc. with a value of $4.93B.

Examining the 13F form we can see an decrease of $14K in the current position value, from $377B to 377B.

Barclays PLC is based out at London, X0

Below you can find more details about Barclays PLC portfolio as well as his latest detailed transactions.

Portfolio value $377 Billion
ETFs: $135 Billion
Technology: $79.1 Billion
Consumer Cyclical: $29.9 Billion
Financial Services: $28.5 Billion
Communication Services: $22.6 Billion
Healthcare: $21.3 Billion
Industrials: $17.8 Billion
Consumer Defensive: $11.7 Billion
Other: $23.6 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$2B
$1.29 Million 0.0% of portfolio
427,023
Q3 2024 Added 272.68%
$4.02B
$6.13 Million 0.0% of portfolio
302,610
Q3 2024 Added 124.22%
$972M
$9,000 0.0% of portfolio
1,084
Q3 2024 New
$4.72B
$7.75 Million 0.0% of portfolio
81,782
Q3 2024 Added 330.93%
$507M
$1.56 Million 0.0% of portfolio
67,415
Q3 2024 Added 54.97%
$1.07B
$1.82 Million 0.0% of portfolio
118,693
Q3 2024 Added 48.97%
$885M
$2.36 Million 0.0% of portfolio
253,392
Q3 2024 Added 148.15%
$1.74B
$1.45 Million 0.0% of portfolio
385,653
Q3 2024 Reduced 11.93%
$799M
$3.77 Million 0.0% of portfolio
547,325
Q3 2024 Added 24.95%
Ardent Health Partners Inc
-
$385,000 0.0% of portfolio
-
Q3 2024 New
$484M
$1.06 Million 0.0% of portfolio
58,431
Q3 2024 Added 301.06%
$0
$2.61 Million 0.0% of portfolio
124,728
Q3 2024 Reduced 50.66%
$331M
$489,000 0.0% of portfolio
69,821
Q3 2024 Added 279.75%
$2.17B
$6.73 Million 0.0% of portfolio
66,341
Q3 2024 Added 46.62%
$35.9B
$166,000 0.0% of portfolio
305
Q3 2024 New
$516M
$3.98 Million 0.0% of portfolio
323,105
Q3 2024 Added 283.96%
$636M
$592,000 0.0% of portfolio
35,102
Q3 2024 Added 276.95%
$0
$3.1 Million 0.0% of portfolio
65,166
Q3 2024 Added 100.59%
$0
$7.3 Million 0.0% of portfolio
285,108
Q3 2024 Added 252.75%
$0
$0 0.0% of portfolio
18
Q3 2024 Added 20.0%
$0
$1,000 0.0% of portfolio
22
Q1 2024 Reduced 95.14%
$777M
$1.2 Million 0.0% of portfolio
171,600
Q3 2024 Added 98.17%
$1.01B
$2.24 Million 0.0% of portfolio
185,281
Q3 2024 Added 234.49%
$674M
$2.33 Million 0.0% of portfolio
215,192
Q3 2024 Added 73.92%
Armour Residential Reit Inc
-
$2.54 Million 0.0% of portfolio
-
Q3 2024 Added 300.57%
$6.52B
$2.92 Million 0.0% of portfolio
22,233
Q3 2024 Added 44.9%
$145M
$196,000 0.0% of portfolio
33,350
Q3 2024 Added 286.94%
$998M
$2.39 Million 0.0% of portfolio
361,778
Q3 2024 Added 159.35%
Arrivent Biopharma Inc
-
$976,000 0.0% of portfolio
-
Q3 2024 Added 1,124.84%
$447M
$614,000 0.0% of portfolio
21,411
Q3 2024 Added 251.92%
$2.06B
$5.36 Million 0.0% of portfolio
276,610
Q3 2024 Added 153.64%
$0
$1.62 Million 0.0% of portfolio
111,666
Q3 2024 Added 189.75%
$401M
$304,000 0.0% of portfolio
39,396
Q3 2024 Added 321.12%
$2.82B
$18.6 Million 0.0% of portfolio
430,422
Q3 2024 Added 0.57%
Artiva Biotherapeutics Inc
-
$304,000 0.0% of portfolio
-
Q3 2024 New
$1.18B
$1.89 Million 0.0% of portfolio
70,877
Q3 2024 Added 346.3%
$1.06B
$3 Million 0.0% of portfolio
121,699
Q3 2024 Added 198.9%
$2.74B
$1.92 Million 0.0% of portfolio
165,753
Q3 2024 Added 103.03%
$5.25B
$9.22 Million 0.0% of portfolio
38,644
Q3 2024 Added 94.95%
$7.83B
$2.8 Million 0.0% of portfolio
18,736
Q3 2024 Reduced 1.41%
Ascendis Pharma A/S
-
$1.84 Million 0.0% of portfolio
-
Q3 2024 New
$4.28B
$8.11 Million 0.0% of portfolio
86,995
Q3 2024 Added 159.27%
$3.86B
$6.24 Million 0.0% of portfolio
71,689
Q3 2024 Added 323.09%
Asp Isotopes Inc
-
$201,000 0.0% of portfolio
-
Q3 2024 Added 438.45%
$562M
$2.56 Million 0.0% of portfolio
92,302
Q3 2024 Added 333.79%
Assembly Biosciences Inc
-
$46,000 0.0% of portfolio
-
Q3 2024 Added 1.37%
$42.4M
$8,000 0.0% of portfolio
6,395
Q3 2024 Reduced 76.24%
$3.63B
$8 Million 0.0% of portfolio
371,448
Q3 2024 Added 51.27%
$108M
$14,000 0.0% of portfolio
393
Q3 2024 New

Summary

  • Portfolio
  • No. of Stocks 9,207
  • Current Value $377 Billion
  • Prior Value $377 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 19, 2024
  • Form Type 13F-HR/A
  • Activity in Q3 2024
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email